Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Sales | 5,365 | 12,427 | 0 | 0 |
| Gross Profit | 5,365 | 12,427 | N/A | N/A |
| Operating Expenses | 12,563 | 11,874 | 0 | 0 |
| Operating Income | -7,198 | 554 | N/A | N/A |
| Interest Expense | 2,655 | 494 | 0 | 0 |
| Other Income | 3 | 6 | 0 | 0 |
| Pre-tax Income | -9,850 | 66 | 0 | 0 |
| Net Income Continuous | -9,850 | 66 | N/A | N/A |
| Net Income | $-9,850 | $66 | $N/A | $N/A |
| EPS Basic Total Ops | -56.80 | 0.80 | N/A | N/A |
| EPS Basic Continuous Ops | -56.80 | 0.45 | N/A | N/A |
| EPS Diluted Total Ops | -56.80 | 0.80 | N/A | N/A |
| EPS Diluted Continuous Ops | -56.80 | 0.45 | N/A | N/A |
| EBITDA(a) | $-6,831 | $939 | $N/A | $N/A |